R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.
R3 Vascular has raised $87.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
R3 Vascular's investors include Deerfield Management, 415 Capital.
R3 Vascular is headquartered in Mountain View, United States.
R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.
R3 Vascular is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"R3 Vascular — Funding & Investors." VCBacked, May 9, 2024, https://www.vcbacked.co/company/r3-vascular. Accessed September 30, 2026.
VCBacked. (2024). R3 Vascular — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/r3-vascular
{{cite web |title=R3 Vascular — Funding & Investors |url=https://www.vcbacked.co/company/r3-vascular |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated